Retractable Technologies (NYSE:RVP) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a research report released on Wednesday. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Down 1.4 %

RVP stock opened at $0.71 on Wednesday. Retractable Technologies has a twelve month low of $0.56 and a twelve month high of $1.23. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. The firm has a market cap of $21.36 million, a PE ratio of -1.32 and a beta of 2.08. The business has a 50 day moving average of $0.78 and a 200 day moving average of $0.75.

Institutional Trading of Retractable Technologies

A hedge fund recently raised its stake in Retractable Technologies stock. Renaissance Technologies LLC raised its holdings in shares of Retractable Technologies, Inc. (NYSE:RVP) by 9.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 361,253 shares of the company’s stock after purchasing an additional 31,140 shares during the period. Renaissance Technologies LLC owned approximately 1.21% of Retractable Technologies worth $249,000 at the end of the most recent quarter. Institutional investors own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.